Aug. 13, 2018 - Dallas, TX, - (GLOBE NEWSWIRE) — Nexeon MedSystems Inc (”Nexeon”) (OTCQB: NXNN), a neurostimulation medical device company,…
Nexeon MedSystems Announces Second Quarter 2018 Financial Results
Nexeon Receives “NXNN” Ticker Symbol from FINRA and Raises $1.165M
Aug. 9, 2018 - Dallas, TX - /PRNewswire/ — Nexeon MedSystems, Inc. (OTCQB:NXNN) announced it has received its ticker symbol from FINRA and will…
Nexeon MedSystems Announces First Quarter 2018 Financial Results
May 21, 2018 - Dallas, TX - (GLOBE NEWSWIRE) — Nexeon MedSystems Inc (”Nexeon”) (OTCQB:NXNN) a neurostimulation medical device company,…
Nexeon MedSystems Announces Fourth Quarter and Full Year Results
DALLAS, April 05, 2018 (GLOBE NEWSWIRE) — Nexeon MedSystems Inc (”Nexeon”) (OTCQB:NXNN) a neurostimulation medical device company, announced today financial…
Nexeon MedSystems Provides Shareholder Update
Company to Host Conference Call November 20, 2017 4pm CST DALLAS, Nov. 20, 2017 /PRNewswire/ — Nexeon MedSystems Inc. (OTCQB:…
Nexeon Closes $4.3 Million in Private Funding Round, Has Form 10 Deemed Effective
Nexeon MedSystems Inc., a biomedical manufacturing medical devices company, has closed a round of funding to expand manufacturing capacity, laying…